ACCESS: Cumulative Event Rate in Patients Receiving Candesartan or Placebo Following an Acute Stroke.
ACCESS=Acute Candesartan Cilexetil Therapy in Stroke Survivors.Reprinted from Stroke, Vol 34/7, 1699–703, Schrader J et al., The ACCESS study: Evaluation of acute candesartan cilexetil therapy in stroke survivors, Copyright 2003, with permission from Lippincott Williams & Wilkins.